Retatrutide + Cagrilintide Blend vs Orforglipron | Research Comparison | QSC

Retatrutide + Cagrilintide Blend vs Orforglipron | Research Comparison

Mechanism, applications and research differences compared

Shop Both at QSC →

Factor Retatrutide + Cagrilintide Blend Orforglipron
Class GLP-1 Class Research Blend Oral GLP-1R agonist
Mechanism Triple GLP-1R/GIPR/GCGR agonism (Retatrutide) + AMY1R agonis GLP-1R (small molecule)
At QSC ✓ In Stock ✓ In Stock
Research Analysis: Orforglipron: oral convenience, 1 receptor. Reta+Cagri: injectable, 4 receptors. Maximum efficacy vs maximum convenience — research trade-off.
Research Use Only. All QSC products for in vitro laboratory research only.
Peptides
Orals
Oils
Search
Contact